ReviewMicrosystems & nanoengineering2025
Wearable bioelectronics for cancer theranostics.
Review in Microsystems & nanoengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Bioelectronic Considerations in Biomedical Microneedles.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Nano-biosensors for circulating tumor markers: advancing liquid biopsy toward precision cancer diagnostics.Journal of cancer research and clinical oncology · 2026Review
- Flexible bioelectronic sensors promote the advancement of wearable ultrasound technology in the medicine.Microsystems & nanoengineering · 2026Review
- Chrono-immunotherapy's current and future optimization strategies: immunotherapy timing in line with the circadian rhythm brings longer survival benefits.Frontiers in immunology · 2026Review
- Smart nanoplatforms for early detection and immune modulation in lung cancer.Frontiers in bioengineering and biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cancer has emerged as a critical global health concern due to its elevated heterogeneity and mortality rate. Despite the continuous efforts put into medical research, current clinical approaches still face limitations, including dependency on costly facilities, trained operators and suboptimal diagnostic precision. Therefore, innovative strategies for accurate, personalized and patient-friendly cancer theranostic solutions are urgently required. Among all the platforms, wearable bioelectronics stand out for advantages such as non-invasive detection, responsive therapy and long-term monitoring, owing to their functional bioelectronic interfaces. This review summarizes the latest advances in wearable bioelectronics, aiming to provide a new strategy for cancer theranostics. Initially, the clinical status and emerging wearable bioelectronics are briefly described to provide a general overview. The subsequent contents focus on the implementation of wearable bioelectronics across early diagnosis, treatment, prognostic monitoring and rehabilitation with multiple device configurations. Finally, we discuss the current challenges and prospective future development in advanced cancer theranostics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.